Related Experiment Video
Updated: Aug 17, 2026

Intracoronary Acetylcholine Provocation Testing for Assessment of Coronary Vasomotor Disorders
Published on: August 18, 2016
Management of chronic stable angina pectoris from a sceptic's view point
1Department of Interventional Cardiology, Batra Hospital & Medical Research Centre, New Delhi.
Insights
Stable angina management requires differentiating it from unstable angina for proper risk stratification. Patients with severe symptoms despite medical therapy benefit from revascularization surgery, improving quality of life.
Area of Science:
- Cardiology
- Internal Medicine
Background:
- Ischaemic heart disease is a major global cause of mortality.
- Angina presents in distinct clinical phases: asymptomatic, stable, progressive, and unstable.
- Differentiating stable from unstable angina is crucial for appropriate risk stratification and management.
Purpose of the Study:
- To outline risk stratification strategies for stable angina patients.
- To detail therapeutic approaches, including pharmacotherapy and revascularization surgery.
- To compare different treatment modalities for stable angina.
Main Methods:
- Clinical parameter assessment for risk stratification.
- Exercise testing for evaluating cardiac event risk.
- Measurement of left ventricular systolic function (ejection fraction) in specific patient groups.
- Review of pharmacotherapy options: aspirin, lipid-lowering agents, beta-blockers, nitrates, calcium antagonists.
- Evaluation of revascularization surgical options: coronary artery bypass grafting and percutaneous transluminal coronary angioplasty.
Main Results:
- Clinical parameters aid in determining the need for exercise testing and cardiac catheterization.
- Left ventricular ejection fraction measurement is vital for guiding therapy in chronic stable angina patients with prior myocardial infarction.
- Exercise testing helps assess future cardiac event risk in symptomatic patients with suspected or known coronary artery disease.
- Pharmacotherapy includes aspirin, lipid-lowering agents, beta-blockers, nitrates, and calcium antagonists.
- Surgical revascularization options include coronary artery bypass grafting and percutaneous transluminal coronary angioplasty.
Conclusions:
- Patients with severe stable angina symptoms impacting quality of life, despite optimal medical management, should be considered for revascularization surgery.
- Effective management of stable angina involves preventing myocardial infarction and death.
- Risk stratification guides the selection of appropriate medical or surgical interventions.
Abstract:
Ischaemic heart disease is a leading cause of death in the world. It has clinically defined phases as: Asymptomatic, stable angina, progressive angina and unstable angina. It is important to differentiate patients of angina into those with stable and unstable angina--risk stratification and management differ in the two groups. Risk stratification of patients with stable angina using clinical parameters helps in development of clearer indication of referral for exercise testing and cardiac catheterisation. Chronic stable angina patients with history of documented myocardial infarction of Q waves on ECG should have measurement of left ventricular systolic function (ie, ejection fraction) as it is important for choosing the appropriate medical or surgical therapy. Symptomatic patients with suspected or known coronary artery disease should usually undergo exercise testing to assess the risk of future cardiac events. The treatment of stable angina has two purposes: To prevent myocardial infarction and death and therapy directed towards preventing death. Pharmacotherapy consists of: Aspirin, lipid lowering agents, beta-blockers, nitrates, short acting dihydropyridine calcium antagonists, etc. For surgery, there are two well established approaches of revascularisation. One is coronary artery by-pass grafting and the other is percutaneous transluminal coronary angioplasty. Studies comparing different treatment modalities are elaborated in this article. In conclusion, it can be said that patients having severe symptoms affecting quality of life despite optimal medical therapy should be referred for revascularisation surgery.
Related Concept Videos
Acute Coronary Syndrome V: Nursing Management
Angina II: Classification
Angina III: Clinical Manifestations and Assessment
Angina IV: Management
Angina V: Nursing Management
Atherosclerosis III: Management

